Ardelyx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. 

CEO
Michael G. Raab
CEOMichael G. Raab
Employees
489
Employees489
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2007
Founded2007
Employees
489
Employees489

ARDX Key Statistics

Market cap
1.60B
Market cap1.60B
Price-Earnings ratio
-25.43
Price-Earnings ratio-25.43
Dividend yield
Dividend yield
Average volume
5.74M
Average volume5.74M
High today
$6.62
High today$6.62
Low today
$6.34
Low today$6.34
Open price
$6.55
Open price$6.55
Volume
3.60M
Volume3.60M
52 Week high
$8.40
52 Week high$8.40
52 Week low
$3.21
52 Week low$3.21

Stock Snapshot

With a market cap of 1.6B, Ardelyx(ARDX) trades at $6.48. The stock has a price-to-earnings ratio of -25.43.

During the trading session on 2026-03-01, Ardelyx(ARDX) shares reached a daily high of $6.62 and a low of $6.34. At a current price of $6.48, the stock is +2.2% higher than the low and still -2.1% under the high.

Trading activity shows a volume of 3.6M, compared to an average daily volume of 5.74M.

Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $8.40 and a low of $3.21.

Over the past 52 weeks, Ardelyx(ARDX) stock has traded between a high of $8.40 and a low of $3.21.

ARDX News

Nasdaq 5h
Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership

Key Points Michael Raab sold 41,666 shares directly on Feb. 24, 2026, for approximately $261,000 at a weighted-average price of $6.25 per share. The sale repr...

Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership
TipRanks 6d
Ardelyx, LPGA announce multi-year partnership

The Ladies Professional Golf Association, LPGA, and Ardelyx (ARDX) announced a multi-year partnership naming Ardelyx as an official corporate pharmaceutical Mar...

Simply Wall St 6d
Ardelyx Is Down 16.3% After Issuing Higher 2026 Product Revenue Guidance and Patent Update

In February 2026, Ardelyx, Inc. reported full-year 2025 revenue of US$407.32 million, up from US$333.62 million, while net loss widened to US$61.6 million, and...

Ardelyx Is Down 16.3% After Issuing Higher 2026 Product Revenue Guidance and Patent Update

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

More ARDX News

Simply Wall St 7d
Assessing Ardelyx Valuation After Strong IBSRELA Growth And Upbeat 2026 Revenue Guidance

Ardelyx (ARDX) has released its full year 2025 results, reporting US$407.32 million in revenue and a net loss of US$61.6 million, along with detailed guidance f...

Assessing Ardelyx Valuation After Strong IBSRELA Growth And Upbeat 2026 Revenue Guidance

People also own

Based on the portfolios of people who own ARDX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.